Blue Jet Healthcare shares may rally 22%, says Motilal Oswal
Motilal Oswal has initiated coverage on Blue Jet Healthcare with a 'buy' rating and a target price of Rs 850, implying a potential upside of 22% from current levels. The brokerage believes…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.